Profil
Dr. Hull has been senior vice president, development and regulatory affairs since March 2000.
From 1978 to 1995, Dr. Hull held positions of increasing responsibility at Burroughs Wellcome Co., a pharmaceutical company, including director of cardiovascular medicine.
From 1995 to 2000, Dr. Hull held senior management positions at Quintiles Transnational Corp., a provider of global contract product development and commercialization services, including group vice president.
Dr. Hull currently serves as an adjunct clinical professor at the University of North Carolina School of Pharmacy.
Dr. Hull received his doctorate in pharmacy from the University of North Carolina, Chapel Hill.
Anciens postes connus de J. Heyward Hull
| Sociétés | Poste | Fin |
|---|---|---|
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Corporate Officer/Principal | 17/05/2006 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Health Technology |
















